Vaccination Coverage, Timeliness and Adverse Events Following Immunization in Children with Medical Conditions -

Yudan Song1, Xiang Zeng2, Shaonan Liu3

  • 1National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases (NITFID), Center for National Immunization Program, Chinese Center for Disease Control and Prevention & Chinese Academy of Preventive Medicine, Beijing, China.

China CDC Weekly
|July 11, 2026
PubMed

Insights

Children with medical conditions have high vaccination rates, but those with brain, immune, or congenital disorders are at higher risk. Improving vaccination practices for these vulnerable children is crucial for preventing diseases.

Area of Science:

  • Pediatrics
  • Immunology
  • Public Health

Background:

  • Children with underlying medical conditions are susceptible to vaccine-preventable diseases.
  • Undertaking vaccination is essential for this population to mitigate health risks.

Purpose of the Study:

  • To evaluate vaccination coverage and timeliness in a large cohort of children with medical conditions.
  • To identify specific subgroups of children with medical conditions who may have lower vaccination rates.
  • To analyze delays in vaccination and adverse events following immunization.

Main Methods:

  • A multicenter retrospective study was conducted.
  • Data from 24,966 children with various medical conditions were analyzed.
  • Vaccination coverage, timeliness, delays, and adverse events were assessed.

Main Results:

  • Median coverage for 10 National Immunization Program vaccines was 97.33%, with timely completion at 89.21%.
  • Children with brain, immune, or congenital disorders showed significantly lower vaccination coverage.
  • Vaccination delays were more pronounced after diagnosis compared to before diagnosis.
  • The rate of adverse events following immunization was 23.7 per 100,000 doses administered.

Conclusions:

  • While overall vaccination coverage is high, specific vulnerable groups require targeted interventions.
  • Addressing post-diagnosis vaccination delays is critical for improving immunization rates in children with complex medical conditions.
  • Further research and integration of advanced practices are needed to enhance vaccination uptake in these populations.
Abstract

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
Smallpox01:24

Smallpox

Smallpox is a severe contagious disease caused by the Variola major virus, a double-stranded DNA member of the Poxviridae family.Variola major transmission occurs primarily via inhalation of virus-laden droplets or direct contact with infectious scabs. The incubation period averages approximately seven days, although it may range from 7 to 17 days depending on the inoculum and host factors.Clinically, the prodromal phase is marked by an abrupt onset of high fever, malaise, headache, and myalgia.
Infectious Diseases and Their Occurrence01:28

Infectious Diseases and Their Occurrence

Infectious diseases appear in populations through various transmission patterns, influenced by pathogen characteristics, population immunity, environmental conditions, and social behavior. Understanding these patterns is essential for effective public health surveillance and intervention. These categories—sporadic, outbreak, epidemic, pandemic, and endemic—help frame the nature and scope of disease events.Sporadic diseases occur irregularly and infrequently, without a predictable temporal or...
Vaccines01:21

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
Pharmacovigilance01:19

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Chickenpox01:20

Chickenpox

Chickenpox is an acute, highly contagious disease caused by the varicella-zoster virus (VZV), a double-stranded DNA virus belonging to the Herpesviridae family. Its transmission occurs primarily through the inhalation of respiratory droplets or direct contact with vesicular fluid from skin lesions. The incubation period typically ranges from 10 to 21 days, during which the virus replicates and disseminates through sequential phases within the host. Although generally self-limiting in children,...